EnChannel Medical to Acquire Acutus Medical AcQMap™ Electrophysiology Assets
Deal News | Jul 01, 2025 | PR Newswire Cision EnChannel Medical Ltd.
EnChannel Medical Ltd., an innovator in cardiac electrophysiology, has finalized an agreement to acquire the AcQMap™ imaging and mapping platform assets from Acutus Medical Inc. This acquisition includes crucial intellectual property, regulatory and quality documentation, clinical data, and a selection of AcQMap™ systems and related catheter devices for R&D. The transaction strengthens EnChannel's intellectual property portfolio, integrating key advances in non-contact mapping technologies, pivotal for full-chamber atrial fibrillation (AF) mapping. Non-contact mapping offers a more efficient and comprehensive visualization of AF dynamics compared to traditional contact mapping systems. EnChannel aims to utilize the acquired technologies to pave the way for precise, individualized treatments for persistent AF. Founded by a team from the US and China, EnChannel is committed to advancing AF care through innovative, data-driven solutions. The company's proprietary Action Potential Mapping represents a third-generation leap in non-contact mapping, enhancing the accuracy of AF diagnostics and treatments.
Sectors
- Healthcare Technology
- Medical Devices
Geography
- United States – EnChannel Medical and Acutus Medical are both engaged in a transaction involving assets located or operated within the United States.
- China – EnChannel Medical has founders and operations linked to China, signaling a cross-border business influence.
Industry
- Healthcare Technology – The article highlights the acquisition of advanced electrophysiology assets, indicating innovation in healthcare technologies for cardiac treatment.
- Medical Devices – The acquisition involves sophisticated medical devices and platforms focused on electrophysiology and atrial fibrillation mapping.
Financials
- Not Disclosed – The financial terms of the acquisition between EnChannel Medical Ltd. and Acutus Medical Inc. have not been disclosed.
Participants
| Name | Role | Type | Description |
|---|---|---|---|
| EnChannel Medical Ltd. | Buyer | Company | A company specializing in cardiac electrophysiology, aiming to innovate atrial fibrillation diagnosis and treatment. |
| Acutus Medical Inc. | Target Company | Company | A medical technology company providing electrophysiology solutions, including the AcQMap platform. |
| Jun Feng | CEO | Person | CEO of EnChannel Medical, responsible for strategic acquisitions and overseeing company growth. |
| Graydon Beatty | CSO | Person | Chief Scientific Officer at EnChannel Medical, influential in technology innovation and non-contact mapping advancements. |